Hypogammaglobulinemia, infections and COVID-19 in people with multiple sclerosis treated with ocrelizumab

OBJECTIVE: To determine the influence of immunoglobulins (Ig) level on the rate of infections in people with multiple sclerosis (pwMS) treated with ocrelizumab. METHODS: We enrolled 109 consecutive pwMS treated with ocrelizumab with a mean follow-up of 2.69±0.56 (1.36-4.27) years. We have retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Habek, Mario, Piskač, Dominik, Gabelić, Tereza, Barun, Barbara, Adamec, Ivan, Krbot Skorić, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994678/
https://www.ncbi.nlm.nih.gov/pubmed/35429819
http://dx.doi.org/10.1016/j.msard.2022.103798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994678/
https://www.ncbi.nlm.nih.gov/pubmed/35429819
http://dx.doi.org/10.1016/j.msard.2022.103798

Ejemplares similares